73 / 100
|IIT Delhi collaborated with AIST, an institute in Japan, in a study that discovered that Ashwagandha may hold an efficient anti-COVID-19 drug.|
|A collaborative study by DAILAB in IIT Delhi and in AIST (National Institute of Advanced Industrial Science and Technology), Japan has recently discovered that Ashwagandha may hold an efficient anti-COVID-19 drug. Prof. D Sundar, Coordinator of DAILAB at IIT Delhi and Head of the Department of Biochemical Engineering and Biotechnology at IIT Delhi, was one of the main minds behind the study.|
The research team found that natural compounds from Ashwagandha and propolis have the potential to be effective anti-COVID-19 drug candidates.
Natural compounds from Ashwagandha and propolis can be anti-COVID-19 drugs. In a research paper, just accepted for publication in the J Biomol Struct Dyn, the research team has reported that natural compounds from Ashwagandha and propolis have the potential to be effective anti-COVID-19 drug candidates.
The researchers targeted the main SARS-CoV-2’s enzyme for splitting proteins, known as the Main protease or Mopar that plays a key role in mediating viral replication.
This is an attractive drug target for this virus, and as humans don’t naturally have this enzyme, compounds that target Mpro are likely to have low toxicity.
They discovered that Withanone (Wi-N), a natural compound derived from Ashwagandha (Withania somnifera) and Caffeic Acid Phenethyl Ester (CAPE), an active ingredient of New Zealand propolis, have the potential to interact with and block the activity of Mpro.
The team described that they have also searched for the capability of these bioactive to modulate the protein on the surface of human cells, to which the SARS-CoV-2 binds and allows its entry into our cell – the transmembrane protease serine 2 (TMPRSS2), and selected Withanone.
The study is currently under review and expected to be published in the near future.
IIT Delhi study on Ashwagandha can save time and money needed to screen Covid-19 drugs
The research team said that their findings may not only connect to save time and cost required for screening for anti-COVID-19 drugs, but may also offer some preventive and therapeutic value for the management of fatal Covid-19 pandemic, and hence warrant prioritized validation in the laboratory and clinical tests.
They added that drug development may take a while and in the current scenario, these natural resources (Ashwagandha and Propolis) may offer some preventive or even therapeutic value.